Document:

Document

Exhibit 10.1

TALEND
STOCK OPTION GRANT AGREEMENT
Part I
NOTICE OF STOCK OPTION GRANT

[Optionee's Name and Address]

You have been granted a total number of [__●__] [Options (the “Options”)][, corresponding to] [[__●__] Options called “Base Options”] [and] [[__●__] Options called “Performance Options”][,]  to subscribe ordinary Shares of the Company, subject to the terms and conditions of the 2017 Stock Option Plan (the "Plan") and this Stock Option Grant Agreement (the "Option Agreement"). Options are governed by articles L. 225-177 and following of the French Commercial Code. They are not part of the employment agreement or of the office which has allowed the Optionee to be granted the Options. Neither do they constitute an element of the Optionee’s remuneration. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Option Agreement.

Grant Number:                                                
[Base Options  :   _________________]
[Performance Options:  _________________]
Total number of Options:  _________________

Date of Grant:                                                 
Vesting Commencement Date:                         
[Base Options:                         [__o__]]
[Performance Options:             [__o__]]
Exercise Price per Share:   EUR ______________
Total Number of Shares Granted:  _________________
Total Exercise Price:    EUR ______________
Type of Options:    [Incentive Stock Option]
[Nonstatutory Stock Option]
Term/Expiration Date:    [__o__] years – [__o__]

Where the exercise of an Option, as described under Article 9.(a) of the Plan, would lead the Company to be liable for any payment, whether due to fees, taxes or to charges of any nature whatsoever, in place of the Optionee, such Option shall be deemed duly exercised when the full payment for the Shares with respect to which the Option is exercised is executed by the Optionee and the Optionee provides the Company with either the receipt stating the payment by the Optionee of any such fee, tax or charge, as above described that would otherwise be paid by the Company upon exercise of the Option, in place of the Optionee or, the full payment, under the same conditions, of any amount due upon the exercise of the Option to be borne by the Company.

In the event that you infringe the above mentioned commitment, you shall be liable for any consequences resulting from such infringement for the Company and undertake to indemnify the Company in respect of all amounts payable by the Company in connection with such infringement.

Validity of the Options:

The Options will be valid as from the Date of Grant.

Vesting Schedule:

The Options[, depending on whether they are Base or Performance Options,] may be exercised by the Beneficiary on the basis of the following initial vesting schedule subject to the condition precedent that the Optionee shall have previously returned to the Company a copy of Part I and Part II of this Option Agreement as duly signed by him or her:

[To be adapted by the Board upon the type of Options granted]

[(i) For Base Options:]

–[insert vesting schedule]

[(ii) For Performance Options:]

–[insert vesting schedule]

The number of Options that could be exercised pursuant to the above vesting schedule will always be rounded down to the nearest full number.

If the Beneficiary fails to exercise the Options in whole or in part within the above period of ten (10) years (as may be extended to six (6) months from the death or nine (9) months from the Disability of the Optionee (except with respect to Options granted to U.S. Beneficiaries for whom the ten (10)-year period cannot be extended)), the Options will lapse automatically.

Termination Period:

Unless otherwise decided by the Board prior to their expiration, the Options may be exercised for three (3) months after termination of the Optionee's Continuous Status as a Beneficiary, to the extent the Options are exercisable at the time of termination and whether such termination is due to the Optionee or the Company’s decision. 

Upon the death of the Optionee, the Options may be exercised during a period of six (6) months as provided in the Plan. 

Unless otherwise decided by the Board, upon the Disability of the Optionee, the Options may be exercised during a period of nine (9) months as provided in the Plan. 

Save as provided in the Plan, in no event shall the Options be exercised later than the Term/Expiration Date as provided above. Should the Options expire or become unexercisable for any reason without having been exercised in full, the unsubscribed Shares which were subject thereto shall, unless the Plan shall have been terminated, become available for future grant under the Plan.

By his signature and the signature of the Company's representative below, the Optionee and the Company agree that the Options are granted under and governed by the terms and conditions of the Plan and this Option Agreement. The Optionee has reviewed the Plan and this Option Agreement in their entirely, has had the opportunity to obtain the advice of counsel prior to executing this Option Agreement and fully understands all provisions of the Plan and Option Agreement. The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions relating to the Plan and Option Agreement. The Optionee further agrees to notify the Company upon any change in the residence address indicated below.

TALEND
STOCK OPTION GRANT AGREEMENT
Part II
TERMS AND CONDITIONS

            1.         Grant of Options. 

1.1.      The Administrator of the Company hereby grants to the Optionee named in the Notice of Grant attached as Part I of this Option Agreement (the "Optionee"), a total number of [__●__] [Options (the “Options”)][, corresponding to] [[__●__] Options called “Base Options”] [and] [[__●__] Options called “Performance Options”][,]  to subscribe the number of ordinary Shares, as set forth in the Notice of Grant, at the exercise price per Share set forth in the Notice of Grant (the "Exercise Price"), subject to the terms and conditions of the Plan, which is incorporated herein by reference. 

In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Option Agreement, the terms and conditions of the Plan shall prevail.

If designated in the Notice of Grant as an Incentive Stock Option, this Option is intended to qualify as an Incentive Stock Option under Section 422 of the Code although the Company makes no representation as to the tax status of the Option. However, if this Option is intended to be an Incentive Stock Option, to the extent that it exceeds the U.S.$ 100,000 rule of Code Section 422(d) the excess shall be treated as a Non-Statutory Stock Option.

            1.2.      An Option will be valid as from the Date of Grant.

            1.3.      In the event of any tax liability arising on account of the Grant of the Options, the liability to pay such taxes shall be that of the Beneficiary alone. The Beneficiary shall enter into such agreements of indemnity and execute any and all documents as the Company may specify for this purpose, if so required at the time of the Grant and at any other time at the discretion of the Company, on such terms and conditions as the Company may think fit, for recovery of the tax due, from the Beneficiary.

            2.         Exercise of Options

(a)        Right to Exercise. An Option[, whether a Base or Performance Option,] is exercisable during its term in accordance with the Vesting Schedule set out in the Notice of Grant and the applicable provisions of the Plan and this Option Agreement, subject to the condition precedent that the Optionee shall have previously returned to the Company a copy of Part I and Part II of this Option Agreement provided to you by the Company and as duly signed 
by you on signature page.  In the event of Optionee's death, Disability or other termination of Optionee's Continuous Status as a Beneficiary, the exercisability of an Option is governed by the applicable provisions of the Plan and this Option Agreement.

(b)        Method of Exercise. An Option is exercisable by delivery of an exercise notice, in the form attached as Exhibit A hereto (or in such other form acceptable to the Administrator) (the "Exercise Notice"), comprising a share subscription form (bulletin de souscription) which shall state the election to exercise the Option, the number of Shares in respect of which the Option is being exercised (the "Exercised Shares"), and such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Exercise Notice shall be signed by the Optionee and shall be delivered in person or by certified mail to the Company or its designated representative or by facsimile message to be immediately confirmed by certified mail to the Company or through an electronic platform or means of communication acceptable to the Administrator. The Exercise Notice shall be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares. An Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by the proof of payment of such aggregate Exercise Price.

No Share shall be issued pursuant to the exercise of an Option unless such issuance and exercise complies with all relevant provisions of law as set out under Section 14(a) of the Plan.

Upon exercise of an Option, the Shares issued to the Optionee shall be assimilated with all other Shares of the Company and shall be entitled to dividends for the fiscal year in course during which the Option is exercised.

            3.         Method of Payment. Payment of the aggregate Exercise Price shall be by any of the following, or a combination thereof, at the election of the Optionee:

(1)       wire transfer with the execution of the corresponding exchange contract;
                        (2)        check; or
                        (3)        any combination of the foregoing methods of payment.

Where the exercise of an Option would lead the Company to be liable for any payment, whether due to fees, taxes or to charges of any nature whatsoever, in place of the Optionee, such Option shall be deemed duly exercised when (a) the full payment for the Shares with respect to which the Option is exercised is executed by the Optionee and (b) the Optionee provides the Company with either (i) the receipt stating the payment by the Optionee of any such fee, tax or charge, as above described that would otherwise be paid by the Company upon exercise of the Option, in place of the Optionee or, (ii) the full payment, under the same conditions, of any amount due upon the exercise of the Option to be borne by the Company.

The Company and its Affiliated Companies may not be held responsible in any way if the Beneficiary for any reason not attributable to the Company or any Affiliated Company was not able to exercise the Option or purchase the Shares.   The payment for the purchase of the Shares shall be made by the Optionee under his/her own responsibility according to the terms and conditions set out in this Option Agreement and the Plan.

            4.         Non-Transferability of Option. An Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised during the lifetime of the Optionee only by the Optionee. The terms of the Plan and this Option Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of the Optionee.

            5.         Term of Options. Subject to and as provided in the Plan, an Option may be exercised only within the term set out in the Notice of Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Option Agreement.

            6.         Entire Agreement; Governing Law; Choice of Venue. The Plan is incorporated herein by reference. The Plan and this Option Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Optionee with respect to the subject matter hereof, and may not be modified adversely to the Optionee's interest except by means of a writing signed by the Company and Optionee. This agreement is governed by the laws of the Republic of France.

                        Any claim or dispute arising under the Plan or this Option Agreement shall be subject to the exclusive jurisdiction of the court competent for the place of the registered office of the Company.

            7.         Tax Obligations. Regardless of any action the Company or Optionee’s employer (the “Employer”) takes with respect to any or all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to the Optionee’s participation in the Plan and legally applicable to Optionee (“Tax-Related Items”), Optionee acknowledges that the ultimate liability for all Tax-Related Items legally due by Optionee is and remains Optionee’s responsibility and may exceed the amount actually withheld by the Company or the Employer, if any. The Optionee further acknowledges that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Options, including the grant, vesting or exercise of an Option, the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends or other distributions on the Shares; and (2) do not commit to structure the terms of the grant or any aspect of the Options to reduce or eliminate Optionee’s liability for Tax-Related Items or achieve any particular tax result.  

Prior to any relevant taxable or tax withholding event, Optionee agrees to make appropriate arrangements with the Company and/or the Employer for satisfaction of all Tax-Related Items.  In this regard, Optionee authorizes the Company and/or the Employer to satisfy any withholding obligation for Tax-Related Items by withholding from Optionee’s compensation paid to Optionee by the Company and/or Employer or from proceeds of the sale of Shares.  Alternatively, or in addition, if permissible under Applicable Laws, the Company may sell or arrange for the sale of Shares that Optionee acquires to meet the withholding obligation for Tax-Related Items.  Finally, Optionee will pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold as a result of Optionee’s participation in the Plan or Optionee’s purchase of Shares that cannot be satisfied by the means previously described.  

Depending on the withholding method and to the extent permitted under the Plan and Applicable Laws, the Company and/or the Employer may withhold or account for Tax-Related Items by considering statutory withholding amounts or other applicable withholding rates, including maximum rates applicable in a jurisdiction (in which case Optionee will receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent amount in Shares).

If Optionee is subject to Tax-Related Items in more than one jurisdiction, Optionee acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

The Company may refuse to honor the exercise and refuse to deliver the Shares issuable upon exercise of the Options if Optionee fails to comply with Optionee’s obligations in connection with the Tax-Related Items as described in this section.

For Optionees residing and/or working outside of France, please also refer to Applicable Laws sections of your country set forth in the attached Exhibit B.

            8.         Nature of Grant.  In accepting the grant, Optionee acknowledges that:

(a)  the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, unless otherwise provided in the Plan and this Option Agreement;

(b)  the grant of the Options is voluntary and occasional and does not create any contractual or other right to receive future grants of options, or benefits in lieu of options, even if options have been granted repeatedly in the past;

(c)  all decisions with respect to future option grants, if any, will be at the sole discretion of the Company;

(d)  Optionee’s participation in the Plan shall not create a right to further employment with the Employer and shall not interfere with any ability of the Employer to terminate Optionee’s employment relationship;
(e)  Optionee is voluntarily participating in the Plan;

(f)  the Options are an extraordinary item that does not constitute compensation of any kind for services of any kind rendered to the Company or the Employer, and which is outside the scope of Optionee’s employment contract, if any;

(g)  the Options are not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long service awards, pension or retirement benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company or the Employer;

(h)  the Option grant will not be interpreted to form an employment contract with the Company, the Employer or any Affiliated Company;

(i)   the future value of the underlying Shares is unknown and cannot be predicted with certainty;

(j)   if the underlying Shares do not increase in value, the Options will have no value;

(k)  if Optionee exercises the Options and obtains Shares, the value of those Shares acquired upon exercise may increase or decrease, even below the Exercise Price;

(l)   in consideration of the grant of the Options, no claim or entitlement to compensation or damages shall arise from termination of the Option or diminution in value of the Options or Shares purchased through exercise of an Option resulting from termination of Optionee’s employment the Company or the Employer (for any reason whatsoever) and Optionee irrevocably releases the Company and the Employer from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by signing this Option Agreement, Optionee shall be deemed irrevocably to have waived Optionee’s entitlement to pursue such claim; and 

(m) in the event of termination of Optionee’s employment, Optionee’s right to receive the Option and vest in an Option under the Plan, if any, will terminate effective as of the date that Optionee receives notice of termination regardless of when such termination is effective; furthermore, in the event of termination of employment, Optionee’s right to exercise an Option after termination of employment, if any, will be measured by the date on which the Optionee receives notice of termination; the Company shall have the exclusive discretion to determine when Optionee has terminated for purposes of the Options.  In addition, any period of notice or compensation in lieu of such notice, that is given or ought to have been given under any contract, statute, common law or civil law shall be excluded from Optionee’s period of employment for purposes of the Options.

            9.         No Advice Regarding Grant. The Company is not providing any tax, legal, or financial advice nor is the Company making any recommendations regarding the Optionee’s participation in the Plan or the Optionee’s acquisition or sale of the underlying Shares.  The Optionee should consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.

            10.         Data Privacy.  
For Optionees in the European Union / European Economic Area / Switzerland / United Kingdom

The Optionee is hereby informed that the Company will process personal data of the Optionee for the exclusive purpose of implementing, administering and managing the Optionee’s participation in the  Plan. Such processing of personal data implies the collection, use and transfer, in electronic or other form, of the Optionee’s personal data as described in this document by and among, as applicable, the Employer, the Company and any other Affiliated Company.  The legal basis of such processing is the performance of the grant.

            The Optionee understands that the Company and the Employer may hold certain personal information about the Optionee, including, but not limited to, the Optionee’s name, home address and telephone number, e-mail address, date of birth, social insurance number or other identification number (e.g., resident registration number), salary, nationality, passport number, job title, any shares or directorships held in the Company, details of all Options or any other entitlement to shares awarded, canceled, exercised, vested, unvested or outstanding in the Optionee’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan. The Company may collect such Data from the Employer.

            The Optionee understands that Data may be transferred to Solium Shareworks or any other third parties assisting, as data processors, in the implementation, administration and management of the Plan.  The Optionee understands that the recipients of Data may be located in the United States or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Optionee’s country.  When required for transfers of the Data to a recipient located in a country outside of the EU, the Company implements adequate legal safeguards such as appropriate contractual clauses.  The Optionee understands that he or she may request a list with the names and addresses of any potential recipients of Data, as well as confirmation of the legal safeguards implemented – and a copy of the contractual clauses securing the transfer, if any –  by contacting the Optionee’s local human resources representative. The Optionee authorizes the Company, Solium Shareworks and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Optionee’s participation in the Plan, including any requisite transfer of such Data to Solium Shareworks or another third party with whom the Optionee may elect to deposit any Shares received under the Plan. 

            The Optionee understands that Data will be held only as long as is necessary to implement, administer and manage the Optionee’s participation in the Plan.  The Optionee understands that he or she may, at any time access the Data, require any necessary amendments to Data, exercise its rights to erasure and restriction, right to object, right to Data portability, by contacting the Optionee’s local human resources representative.  

            The processing of the Optionee’s Data is necessary for the performance of the grant. If the Optionee objects to the processing of his/her Data in relation to the grant, his or her employment status would not be affected; the only consequence of such objection is that the Company would not be able to grant the Options to the Optionee or administer or maintain the Options.  Therefore, the Optionee understands that objecting to the processing may affect the Optionee’s ability to participate in the Plan. The Optionee also has the right to lodge a complaint with a supervisory authority in relation to the processing of his/her Data.

For Optionees outside the European Union / European Economic Area / Switzerland / United Kingdom

The Optionee hereby explicitly and unambiguously consents to the processing of personal data of the Optionee for the exclusive purpose of implementing, administering and managing the Optionee’s participation in the Plan. Such processing of personal data implies the collection, use and transfer, in electronic or other form, of the Optionee’s personal data as described in this document by and among, as applicable, the Employer, the Company and any other Affiliated Company.  The legal basis of such processing is the Optionee's consent.

            The Optionee understands that the Company and the Employer may hold certain personal information about the Optionee, including, but not limited to, the Optionee’s name, home address and telephone number, e-mail address, date of birth, social insurance number or other identification number (e.g., resident registration number), salary, nationality, passport number, job title, any shares or directorships held in the Company, details of 
all the Options or any other entitlement to shares awarded, canceled, exercised, vested, unvested or outstanding in the Optionee’s favor (“Data”), for the exclusive purpose of implementing, administering and managing the Plan. The Company may collect such Data from the Employer.

            The Optionee understands that Data may be transferred to Solium Shareworks or any other third parties assisting in the implementation, administration and management of the Plan.  The Optionee understands that the recipients of Data may be located in the United States or elsewhere, and that the recipient’s country may have different data privacy laws and protections than the Optionee’s country. The Optionee understands that he or she may request a list with the names and addresses of any potential recipients of Data by contacting the Optionee’s local human resources representative. The Optionee authorizes the Company, Solium Shareworks and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the  Plan to receive, possess, use, retain and transfer Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Optionee’s participation in the  Plan, including any requisite transfer of such Data to Solium Shareworks or another third party with whom the Optionee may elect to deposit any Shares received under the Plan. 

            The Optionee understands that Data will be held only as long as is necessary to implement, administer and manage the Optionee’s participation in the Plan.  The Optionee understands that he or she may, at any time access the Data, require any necessary amendments to Data, exercise its rights to erasure and restriction, right to object, right to Data portability, by contacting the Optionee’s local human resources representative.

            Further, the Optionee understands that he or she is providing the consents herein on a purely voluntary basis. If the Optionee does not consent, or if the Optionee later seeks to withdraw his or her consent, his or her employment status would not be affected; the only consequence of refusing or withdrawing consent is that the Company would not be able to grant the Options to the Optionee or administer or maintain the Options.  Therefore, the Optionee understands that refusing or withdrawing the Optionee’s consent may affect the Optionee’s ability to participate in the Plan.  For more information on the consequences of refusal to consent or withdrawal of consent, the Optionee may contact the Optionee’s local human resources representative.

            11.         Country-Specific Provisions.  The Options and any Shares subject to or acquired pursuant to the Options shall be subject to any special terms and conditions set forth for the Optionee’s country in Exhibit B.  Moreover, if the Optionee relocates to one of the countries included in Exhibit B, the special terms and conditions for such country will apply to the Optionee to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons.

            12.         Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Options and any Shares subject to or acquired pursuant to the Options, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Optionee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

            13.         Exchange Control, Tax and/or Foreign Asset/Account Reporting. The Optionee acknowledges that there may be exchange control, tax, foreign asset and/or account reporting requirements which may affect the Optionee’s ability to acquire or hold Shares acquired under the Plan or cash received from participating in the  Plan (including from any dividends or other distributions paid on Shares acquired under the  Plan) in a brokerage/bank account or legal entity outside the Optionee’s country.  The Optionee may be required to report such accounts, assets, the balances therein, the value thereof and/or the transactions related thereto to the tax or other authorities in the Optionee’s country.  The Optionee also may be required to repatriate sale proceeds or other funds received as a result of participation in the  Plan to the Optionee’s country through a designated bank or broker or within a certain time after receipt.  The Optionee acknowledges that it is his or her responsibility to be compliant with such regulations.

            14.         Insider Trading Restrictions / Market Abuse Laws. The Optionee acknowledges that he or she may be subject to insider trading restrictions and/or market abuse laws which may affect the Optionee’s ability to acquire or sell Shares or rights to Shares (e.g., the Options) during such times as the Optionee is considered to have “insider information” regarding the Company (as defined by any applicable law). Any restriction under these laws or 
regulations is separate from and in addition to any restriction that may be imposed under any applicable Company insider trading policy.

            15.         Electronic Delivery and Participation.  The Company may, in its sole discretion, decide to deliver any documents related to the Options and participation in the Plan or future options that may be granted under the Plan by electronic means or to request Optionee’s consent to participate in the Plan by electronic means.  Optionee hereby consents to receive such documents by electronic delivery and, if requested, to agree to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company.

            16.         Waiver. The Optionee acknowledges that a waiver by the Company of breach of any provision of this Option Agreement shall not operate or be construed as a waiver of any other provision of this Option Agreement or of any subsequent breach by the Optionee or any other optionee.

            17.         Severability.  The provisions of this Option Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

OPTIONEE:                                                             talend

_______________________                                     By: _______________________
Signature
_______________________                                     Title: ______________________
Print Name
_______________________
Residence Address
_______________________

EXHIBIT A

TALEND
Société Anonyme having a share capital of EUR.[______]
Registered office: [______]
484 175 252 R.C.S. [___] 

2017 STOCK OPTION PLAN
EXERCISE NOTICE
(Share subscription form)

TALEND
[______]
[______]
France                                                                              [______________], [_]

Attention: [___________]

1.         Exercise of Options. Effective as of today, __________________, __, the undersigned ("Optionee") hereby elects to subscribe _______________ (_____) ordinary shares (the "Shares") of the Common Stock of TALEND (the "Company") under and pursuant to the Company's 2017 Stock Option Plan (the "Plan") adopted by the board on April 20th, 2017 and the Stock Option Agreement dated ___________, __ (the "Option Agreement"). The subscription price for the Shares shall be EUR. ______, as required by the Option Agreement.

2.         Delivery of Payment. Optionee herewith delivers to the Company the full subscription price for the Shares.

3.         Representations of Optionee. The Optionee acknowledges that Optionee has received, read and understood the Plan and the Option Agreement and agrees to abide by and be bound by their terms and conditions.

4.         Rights as Shareholder. Until the issuance (as evidenced by the appropriate entry on the books of the Company) of the Shares, the Optionee shall have, as an Optionee, no right to vote or receive dividends or any other rights as a shareholder shall exist with respect to the Optioned Stock, except those the Optionee may have as a shareholder of the Company. No adjustment will be made for rights in respect of which the record date is prior to the issuance date for the Shares, except as provided in Section 11 of the Plan.

5.         Tax Consultation. The Optionee understands that Optionee may suffer adverse tax consequences as a result of Optionee's subscription or disposition of the Shares. Optionee represents that Optionee has consulted with any tax consultants Optionee deems advisable in connection with the subscription or disposition of the Shares. The Optionee is not relying on the Company for any tax advice.

6.         Entire Agreement; Governing Law. The Plan and Option Agreement are incorporated herein by reference. This Exercise Notice, the Plan and the Option Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Optionee with respect to the subject matter hereof, and may not be modified adversely to the Optionee's interest except by means of a writing signed by the Company and Optionee. This agreement is governed by the laws of the Republic of France. 

*
*     *

This Exercise notice is delivered in two originals one of which shall be returned
to the Optionee.

Submitted by:                                                                   Accepted by:
OPTIONEE (*)                                                                   TALEND

__________________________                                        _______________________
Signature                                                                          Signature

__________________________                                        Its:____________________
Print Name

Address:                                                           

__________________________                                        

__________________________
(*)            The signature of the Optionee must be preceded by the following manuscript mention "accepted for formal and irrevocable subscription of [__________] ordinary Shares".

EXHIBIT B 

TALEND
GLOBAL STOCK OPTION GRANT AGREEMENT
COUNTRY-SPECIFIC PROVISIONS
This Appendix includes additional (or if so indicated, different) terms and conditions that govern the Options if the Optionee is in one of the countries listed herein.  If the Optionee is a citizen or resident of a country (or if Optionee is considered as such for local law purposes) other than the one in which the Optionee is currently residing and/or working, or if the Optionee transfers to another country after being granted the Options, the Company will, in its discretion, determine the extent to which the terms and conditions contained herein will be applicable to the Optionee. 

AUSTRALIA

Nature of Plan.  The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act of 1997 (Cth) (the “Act”) applies (subject to the conditions of the Act).

Securities Law Information. If the Optionee acquires Shares under the Plan and offers the Shares for sale to a person or entity resident in Australia, the offer may be subject to disclosure requirements under Australian law.  The Optionee should obtain legal advice regarding any applicable disclosure obligations before making any such offer in Australia.

CANADA

Securities Law Information.  The Optionee is permitted to sell the Shares acquired under the Plan through the designated broker appointed under the Plan, if any, provided the resale of the Shares acquired under the Plan takes place outside of Canada through the facilities of a securities exchange on which the Shares are listed.  The Shares are currently listed on the Nasdaq.

The following provisions will also apply to Optionees who are resident in Quebec:

Data Privacy.  The following provision supplements Section 10 (Data Privacy) of the Option Agreement:
The Optionee hereby authorizes the Company and the Company’s representatives to discuss with and obtain all relevant information from all personnel, professional or non-professional, involved in the administration and operation of the Plan.  The Optionee further authorizes the Company, any Affiliated Company, as well as a third party service provider, to disclose and discuss the Plan with their advisors and to record all relevant information and keep such information in the Optionee’s employee file.

Language Consent.  The parties acknowledge that it is their express wish that the Option Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.

Consentement Relatif à la Langue Utilisée.  Les parties reconnaissent avoir expressement souhaité que la convention “Option Agreement”, ainsi que tous les documents, avis et procédures judiciaries, éxecutés, donnés ou intentés en vertu de, ou liés, directement ou indirectement à la présente convention, soient rédigés en langue anglaise.

CHINA

Exercise of Option and Method of Payment.  The following provision supplements Section 2 (Exercise of Option) and Section 3 (Method of Payment) of the Option Agreement:
To facilitate compliance with exchange control restrictions in China, the Company reserves the right to (a) restrict the exercise of the Options if the exercise of the Options and the issuance of Shares cannot be done in compliance with the requirements of the State Administration of Foreign Exchange of the People's Republic of China ("SAFE"), (b) require the Optionee to pay the Exercise Price under a cashless exercise program adopted by the Company in 
connection with the Plan whereby no funds are remitted out of China, and/or (c) require that the Optionee sell the Shares acquired upon exercise either immediately upon exercise, upon termination of the Optionee's Continuous Status as a Beneficiary or at such other time the Company determines to be necessary or advisable for legal or administrative reasons. If the Company requires that the Shares must be sold at a particular time, the Optionee acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of Shares at any particular price.

Exchange Control Restrictions.  The Optionee understands and agrees that the Optionee will be required to immediately repatriate to China the cash proceeds from the sale of Shares (and any other funds received in relation to the Options and the Plan). The Optionee further understands that the repatriation of the cash proceeds (and other funds) will need to be effected through a special exchange control account established by the Company, the Employer or any Affiliated Company, and the Optionee hereby consents and agrees that any funds related to the Options and the Plan may be transferred to such special account prior to being delivered to the Optionee. 
The Optionee also understands that the Company will deliver the funds to the Optionee as soon as practicable, but there may be delays in distributing the funds to the Optionee due to exchange control considerations in China. The funds may be paid in U.S. dollars or local currency, at the Company's discretion. If the funds are paid in U.S. dollars, the Optionee understands that he or she will be required to open a U.S. Dollar bank account in China into which the funds can be deposited. If the funds are converted to local currency, the Optionee acknowledges that the Company is under no obligation to secure any particular currency conversion rate, and there may be delays in converting the funds to local currency. The Optionee will bear the risk of any currency conversion rate fluctuation between the date that the Shares are sold (or any other funds are realized) and the date the funds are distributed to the Optionee. 
The Optionee agrees to comply with any requirements that may be imposed by the Company in the future to facilitate compliance with exchange control requirements. 
 
GERMANY

No country-specific provisions.

INDIA

Method of Payment.  The following provision supplements Section 3 (Method of Payment) of the Option Agreement:

To facilitate compliance with regulatory requirements in India, the Company reserves the right to  require the Optionee to pay the Exercise Price under a cashless exercise program adopted by the Company in connection with the Plan whereby no funds are remitted out of India and all Shares acquired upon exercise are sold as soon as practicable after exercise. If the Company requires that the Shares acquired upon exercise are sold as soon as practicable after exercise, the Optionee acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of Shares at any particular price.

Exchange Control Restrictions.  Any funds received in relation to the Plan (e.g., proceeds from the sale of Shares, dividends or other distributions paid on the Shares) must be repatriated to India within such time as may be required under applicable regulations.  This repatriation requirement may impact the ability of the Optionee to pay the Exercise Price via certain methods, e.g., under a cashless exercise program adopted by the Company in connection with the Plan whereby only a portion of the Shares acquired upon exercise are sold to cover the Exercise Price as this may be seen to violate the repatriation requirement.  The Optionee should consult with his or her personal legal advisor to ensure compliance with any applicable requirements.

IRELAND

No country-specific provisions. 

ITALY

Method of Payment.  The following provision supplements Section 3 (Method of Payment) of the Option Agreement:

To facilitate compliance with regulatory requirements in Italy, the Company reserves the right to  require the Optionee to pay the Exercise Price under a cashless exercise program adopted by the Company in connection with the Plan whereby no funds are remitted out of Italy and all Shares acquired upon exercise are sold as soon as practicable after exercise. If the Company requires that the Shares acquired upon exercise are sold as soon as practicable after exercise, the Optionee acknowledges that the Company’s designated broker is under no obligation to arrange for the sale of Shares at any particular price.

Plan Document Acknowledgement.  The Optionee acknowledges that the Optionee has been given access to the Plan, has reviewed the Plan and this Option Agreement in their entirety and fully understands and accepts all provisions of the Plan and this Option Agreement.  Further, the Optionee specifically and expressly approves the following clauses of the Option Agreement: (i) Section 2 – Exercise of Options; (ii) Section 3 - Method of Payment; (iii) Section 6 - Entire Agreement; Governing Law; Choice of Venue; (iv) Section 7 – Tax Obligations; (v) Section 12 - Imposition of Other Requirements; and (vi) Section 15 - Electronic Delivery and Participation.

JAPAN
No country-specific provisions.

NETHERLANDS
No country-specific provisions. 

SINGAPORE

Securities Law Information.  The grant of the Options under the Plan is being made pursuant to the “Qualifying Person” exemption” under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”) and is not made with a view to the Shares being subsequently offered for sale to any other party.  The Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  The Optionee should note that the Options are subject to section 257 of the SFA and the Optionee will not be able to make (i) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the Options in Singapore, unless such sale or offer is made (a) more than six months after the Date of Grant or (b) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).

CEO and Director Notification Information.  If the Optionee is the Chief Executive Officer (“CEO”) or a director, associate director or shadow director of an Affiliated Company in Singapore (a “Singapore Entity”), the Optionee is subject to certain notification requirements under the Singapore Companies Act (to the extent such requirements are determined to be applicable to the Optionee in the case of the CEO). Among these requirements is an obligation to notify the Singapore Entity in writing when the Optionee receives an interest (e.g., Options, Shares) or disposes of an interest in the Company or any related companies.  These notifications must be made within two business days of (i) acquiring or disposing of any interest in the Company or any Affiliated Company or (ii) becoming a director, associate director or shadow director (or, if applicable, the CEO) if such an interest exists at that time.

SPAIN

Nature of Grant.  The following provisions supplement Section 8 (Nature of the Grant) of the Option Agreement:
By accepting the Options, the Optionee acknowledges that he or she has received a copy of the Plan.
The Optionee further acknowledges, understands and agrees that the Company has unilaterally, gratuitously and discretionally decided to grant Options under the Plan to employees of the Company and any Affiliated Company throughout the world.  The decision to grant the Options is a limited decision that is entered into upon the express assumption and condition that any Option grant will not economically or otherwise bind the Company or any Affiliated Company on an ongoing basis other than as set forth in this Option Agreement.  Consequently, the Optionee understands that any grant is given on the assumption and condition that it shall not become a part of any employment contract (either with the Company or any Affiliated Company) and shall not be considered a mandatory 
benefit, salary for any purpose (including severance compensation) or any other right whatsoever.  Further, the Optionee understands and freely accepts that there is no guarantee that any benefit shall arise from any gratuitous and discretionary grant since the future value of the Options and the Shares is unknown and unpredictable. 
 
Additionally, the Optionee understands that the vesting of the Options is expressly conditioned on his or her continued and active rendering of service to the Employer (or the Company or another Affiliated Company) such that if the Optionee’s employment terminates for any reason whatsoever, his or her Options will cease vesting as described in Section 9 of the Plan (except as expressly provided in Article 9 of the Plan).  This will be the case, for example, even if (a) the Optionee is considered to be unfairly dismissed without good cause (i.e., subject to a “despido improcedente”); (b) the Optionee is dismissed for disciplinary or objective reasons or due to a collective dismissal; (c) the Optionee terminates service due to a change of work location, duties or any other employment or contractual condition; (d) the Optionee terminates service due to the Company’s or any Affiliated Company's unilateral breach of contract; or (e) the Optionee’s employment terminates for any other reason whatsoever.  Consequently, upon termination of the Optionee’s employment for any of the above reasons, the Optionee will automatically lose any rights to the Options granted to the Optionee that were unvested on the date of termination of employment and the Optionee must exercise any vested portion of the Option (if at all) within the applicable post termination exercise period, as described in Part I of the Option Agreement.

Finally, the Optionee understands that this grant would not be made to the Optionee but for the assumptions and conditions referred to herein; thus, the Optionee acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of the Options shall be null and void.

Securities Law Information.  No “offer of securities to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the Options. This Option Agreement has not been nor will it be registered with the Comisión Nacional del Mercado de Valores, and does not constitute a public offering prospectus.

SWEDEN

No country-specific provisions.

SWITZERLAND

Securities Law Information. The Optionee should note that neither this document nor any other materials relating to the grant of the Options (i) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (“FinSA”), (ii) may be publicly distributed or otherwise made publicly available  to any person other than an employee of the Company or any Affiliated Company, or (iii) have been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)). 

UNITED KINGDOM

Tax Obligations. The following provision supplements Section 7 (Tax Obligations) of the Option Agreement:
Without limitation to Section 7 of the Option Agreement, the Optionee agrees that the Optionee is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items as and when requested by the Company or any Affiliated Company or by Her Majesty's Revenue and Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Optionee also agrees to indemnify and keep indemnified the Company and any Affiliated Company against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax authority or any other relevant authority) on the Optionee’s behalf.

Notwithstanding the foregoing, if the Optionee is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the terms of the immediately foregoing provision will not apply. In the event that the Optionee is such a director or executive officer and the income tax is not collected from or paid by the Optionee within ninety (90) days of the end of the U.K. tax year in which an event giving rise to the indemnification described above occurs, the amount of uncollected income tax may constitute a benefit to the Optionee on which additional income tax and national insurance contributions may be payable. The Optionee will be responsible for reporting and paying any income tax due on this additional benefit directly to the HMRC under the self-assessment regime and for paying the Company or the Employer, as applicable, for the value of any employee national insurance contributions due on this additional benefit. 
 
UNITED STATES 

Tax Obligations. The following provisions supplement Section 7 (Tax Obligations) of the Option Agreement:
Notice of Disqualifying Disposition of Incentive Stock Option. If the Optionee is a U.S. taxpayer and the Option is an Incentive Stock Option, and the Optionee makes a “disposition” (as defined in Section 424 of the Code) of all or any portion of the Shares acquired upon exercise of the Options within two (2) years from Date of Grant set out in Part I of this Option Agreement or within one (1) year after issuance of the Shares acquired upon exercise of the Options, then the Optionee shall immediately notify the Company in writing as to the occurrence of, and the price realized upon, such disposition.  The Optionee understands that he or she may be subject to income tax withholding by the Company on the compensation income recognized by the Optionee.  

Section 409A of the Code. To the extent the Optionee is or becomes subject to U.S. federal income taxation, this section shall apply.  Under Section 409A of the Code, an Option that was granted with a per Share exercise price that is determined by the U.S. Internal Revenue Service (the “IRS”) to be less than the Fair Market Value of a Share on the Date of Grant (a “discount option”) may be considered “deferred compensation.” An Option that is a “discount option” may result in (a) income recognition by the Optionee prior to the exercise of the Option, (b) an additional 20% federal income tax, (c) potential penalty and interest charges, and (d) additional state income, penalty and interest tax to the Optionee (collectively, “409A Penalties”).  The Optionee acknowledges that the Company cannot guarantee, and has not guaranteed, that the IRS will agree, in a later examination, that the per Share Exercise Price of this Option equals or exceeds the Fair Market Value of a Share on the Date of Grant.  The Optionee agrees that, if the IRS determines that the Option is a “discount option,” the Optionee shall be solely responsible for the Optionee’s costs related to such a determination, including any 409A Penalties. 

*     *     *Document

Exhibit 10.2

Talend

2020 Free share plan

Approved by the Board of Directors on August 4, 2020

Table of contents

												
	1.	Implementation of the free share plan
		1
	2.	Definitions		1
	3.	Purpose		3
	4.	Beneficiaries		3
	5.	Notice of the Grant of the Shares		3
	6.	Vesting Period		4
		6.1.	Principle	4
		6.2.	Internal mobility	5
		6.3.	Disability	5
		6.4.	Death	5
		6.5.	Retirement	5
		6.6.	Change in Control	6
	7.	Holding Period		8
		7.1	Principle	8
		7.2	Specific situations	8
	8.	Characteristics of the Shares		8
	9.	Delivery and holding of the Shares		9
	10.	Intermediary operations		9
	11.	Adjustment		10
	12.	Amendment OF the 2020 Plan		10
		12.1	Principle	10
		12.2	Notice of the amendments	10
	13.	Tax and social rules		10
	14.	Miscellaneous
		11
		14.1	Rights of Beneficiary in his or her capacity of employee or officer	11
		14.2	Term of the 2020 Plan	11
		14.3	Applicable law - Jurisdiction	11
		14.4	Provisions Applicable to Beneficiaries Located Outside of France	11

1.Implementation of the free share plan

Pursuant to a decision dated June 30h, 2020, the combined ordinary and extraordinary general shareholders’ meeting of Talend, a French société anonyme, registered with the French Registry of commerce and companies under number 484 175 252 R.C.S. Nanterre (hereafter referred to as the "Company"), authorized the board of directors of the Company (hereafter referred to as the “Board of Directors”) to grant restricted stock units (“RSUs”) (referred to under French law as free shares) of the Company to the benefit of corporate officers or to certain categories of corporate officers of the Company who meet the conditions set forth by Article L. 225-197-1 II of the French commercial code or employees or to certain categories of employees of the Company and/or of companies or economic interest groups whose share capital or voting rights are held, directly or indirectly, by more than ten percent (10%) by the Company at the date of grant of such shares.

The Board of Directors decided on August 4, 2020, pursuant to the abovementioned authorization of the shareholders’ general meeting and after review and approval by the Compensation Committee of the Board of Directors (the “Compensation Committee”), to adopt this free share plan of the Company setting forth the conditions and criteria for the grant of such shares (hereafter referred to as the "2020 Plan").

2. Definitions

Under the 2020 Plan, the following capitalized terms and expressions used in the 2020 Plan shall have the meaning ascribe to them below:

						
	"Beneficiaries"	means the person(s) to whom the Board of Directors decided to Grant free shares as well as, as the case may be, his or her estate.

	"Bylaws"	means the bylaws of the Company as in force from time to time.

	"Cause"	means the occurrence of any of the following: (i) an act of dishonesty ("déloyauté") made by the Beneficiary in connection with the Beneficiary’s responsibilities as an employee, (ii) the Beneficiary’s conviction of, or plea of nolo contendere to, a felony or any crime involving fraud, embezzlement or any other act of moral turpitude, (iii) the Beneficiary’s violation of any federal, state, or securities law or regulation in a manner detrimental to the business of any member of the Group or of any federal, state, or securities law or regulation applicable to the business of any member of the Group, (iv) the Beneficiary’s unauthorized use or disclosure of any proprietary information or trade secrets of the Group or any other party to whom the Beneficiary owes an obligation of nondisclosure as a result of the Beneficiary’s relationship with the Group, (v) the Beneficiary’s willful and gross misconduct that is or could be materially injurious to any member of the Group; (vi) a material breach of any confidentiality agreement or invention assignment agreement between Beneficiary and any member of the Group, or (vii) the Beneficiary’s continued failure to perform the Beneficiary’s employment duties (other than a failure resulting from the Beneficiary’s “Disability”) after the Beneficiary has received a written demand of performance from the Company which specifically sets forth the factual basis for the Company’s belief that the Beneficiary has not substantially performed the Beneficiary’s duties and has failed to cure such non-performance to the Company’s satisfaction within 10 business days after receiving such notice.

	"Change in Control"	means any of the following events: (i) a merger of the Company into another corporation which is not controlled by the shareholders controlling the Company immediately before the completion of the relevant merger, (ii) the sale by one or several shareholders of the Company, acting alone or in concert, to any acquirer of a number of Shares resulting in a transfer of more than fifty percent (50%) of the Shares and voting rights of the Company to said acquirer, or (iii) the sale of all or almost all assets of the Company to any acquirer which are not controlled by the Company or its shareholders.

	"Change in Control Period"	means the period beginning three months prior to and ending 12 months following the Change in Control.

	"Disability"	means the disability of a Beneficiary corresponding to the second or third categories set forth in article L. 341-4 of the French social security code[1] (or any equivalent fault under applicable employment legislation). A Beneficiary shall not be considered to have incurred a Disability unless he or she furnishes proof of such impairment sufficient to comply with the above definition and satisfy the Company in its discretion

	"Grant"	means the decision of the Board of Directors to grant free Shares (actions gratuites) to Beneficiary(ies) under the 2020 Plan; provided that such Grant shall constitute a right to acquire Shares for free upon expiration of their Vesting Period subject to compliance with the terms and conditions of the 2020 Plan and the Grant Notice.

	"Grant Date"	means the date when the Board of Directors decided to grant free Shares (actions gratuites) under the 2020 Plan.

	"Grant Notice"	means, in case of a Grant, the information notice sent by the Company to the relevant Beneficiaries in order to inform them of the Grant to them of free Shares by the Company under the 2020 Plan, as set forth in Article 5 of the 2020 Plan (including any applicable exhibits and appendices attached thereto).

	"Group"	means the Company together with all its affiliated entities within the meaning of Article L. 225-197-2 of the French commercial code.

	"Holding Period"	means, with respect to a free Share granted to a Beneficiary under the 2020 Plan, the period (if any) starting from its Vesting Date as set forth in such Beneficiary’s Grant Notice.

	“Involuntary Termination”
	means the termination of the Beneficiary’s Presence by the Company or any of the companies of the Group without “Cause” (and not by reason of the Beneficiary’s death or Disability).

	"Presence"	means the presence of the Beneficiary in his or her capacity as an employee and/or corporate officer of the Company or of any of the companies of the Group.

	"Shareholders’ Authorization"	means the authorization granted by the shareholders of the Company, at its meeting held on June 30th, 2020, pursuant to its twentieth resolution, to the Board of Directors to grant free Shares.

	"Shares"	means the ordinary shares issued or to be issued by the Company representing its share capital, whether any such shares are represented by American Depository Receipts (“ADRs”) or not.

	"Vesting Date"
	means, with respect to a free Share granted to a Beneficiary under the 2020 Plan, the date when such free Share is definitively acquired by the relevant Beneficiary as set forth in his or her Grant Notice.

	"Vesting Period"	means, with respect to a free Share granted to a Beneficiary under the 2020 Plan, the period from the Grant Date to the Vesting Date as set forth in the Grant Notice of the relevant Beneficiary.

[1] Note : As at the date of adoption of this 2020 Plan by the Board of Directors, the second or third categories of disable persons set forth in article L. 341-4 of the French social security code are as follows: (i) a disable person unable to carry out any responsibilities and functions or (ii), in addition to being disable under (i) above, a disable person forced to call upon a third party in order to carry out the tasks necessary for everyday life.

3. Purpose

The purpose of the 2020 Plan is to set forth the terms and conditions for the Grant of free Shares in compliance with notably articles L. 225-197-1 et seq. of the French commercial code and the Shareholders’ Authorization. 

4. Beneficiaries

Pursuant to the Shareholders’ Authorization, the Board of Directors shall (i) select the list of Beneficiaries among the officers and/or employees of the Company and/or of companies or economic interest groups whose share capital or voting rights are held, directly or indirectly, by more than ten percent (10%) by the Company at the date of grant of such shares  and (ii) determine the number of free Shares granted to each of them. 

The Grant may be subject, for each Beneficiary, to the agreement of the competent authorities (in particular the regulatory and market surveillance authority, the authorities competent to control foreign exchange and foreign investment or the tax authorities) of the country in which its employer has its registered office and to compliance with the applicable legal and regulatory provisions, in particular stock exchange regulations.

The Beneficiaries shall not be liable for any subscription payment to the Company.

5. Notice of the Grant of the Shares 

In case of a Grant, a Grant Notice must be sent to each relevant Beneficiary by the Board of Directors (or by any delegate thereof) by registered mail (postage prepaid, return receipt requested), by electronic delivery managed by a qualified e-certification provider (prestataire de services de certification électronique) or by hand delivery with acknowledgement of receipt, together with a copy of the 2020 Plan and of the Company's articles of association, which notice shall specify, in particular, the number of Shares granted for free to the Beneficiary, their Vesting Period and, as the case may be, their Holding Period, as well as any country-specific provisions applicable to the Grant pursuant to Article 14.3 below.

The Beneficiary shall acknowledge receipt of the Grant Notice, the 2020 Plan and of the Company's articles of association. To this end, the Beneficiary shall sign (by electronic means if so decided by the Company)copies of these documents within thirty (30) days from the date of receipt, the documents being deemed to have been received by Beneficiary on the date of first delivery.

Any Beneficiary who did not expressly accept the grant within the prescribed period shall be deemed to have definitively waived them without being entitled to any compensation or indemnification from his employer, the Company or any of the Group companies.

In accordance with the provisions of article L. 225-197-1 II of the French Commercial Code, no Beneficiary holds more than 10% of the Company's share capital as at the Grant Date. In addition, no free Shares may result in the Beneficiary holding more than 10% of the Company's share capital following the transfer of ownership of the Shares.

The fact that a person may benefit from the 2020 Plan does not imply that he or she shall benefit from any other plan that may be implemented thereafter. 

6. Vesting Period

6.1. Principle

Any free Share granted under the 2020 Plan shall be definitively acquired by the relevant Beneficiary upon expiration of its Vesting Period, subject to the following conditions being met on the Vesting Date (or such other date, as may be set forth in the Grant Notice):

–continued Presence of the relevant Beneficiary during the Vesting Period (or such shorter period as may be set forth in the Grant Notice) (the “Continuous Presence Condition”); provided that, unless otherwise specified in his or her Grant Notice, should the Continuous Presence Condition no longer be met during the relevant Vesting Period, the relevant Beneficiary shall definitely and irrevocably lose his or her right to acquire the relevant Shares granted to him or her on the date when such condition is no longer met; and

–as the case may be, satisfaction of performance conditions (the “Performance Conditions”) to be determined by the Board of Directors, in its sole discretion, and set forth in the Grant Notice of the relevant Beneficiary;

provided that, at any time during a Vesting Period, the Board of Directors may, in its sole discretion, decide to waive and release the relevant Beneficiary of the Continuous Presence Condition and/or, as the case may be, the Performance Conditions with respect to all or part of his or her free Shares; and

provided further that, pursuant to article L. 225-197-1 of the French commercial code, with respect to any free Share granted under the 2020 Plan: (a) the Vesting Period should be equal to at least one year and (b) the total duration of its Vesting Period and the Holding Period (if any) shall be equal to at least two years from the Grant Date (e.g., in case there is no Holding Period, the Vesting Period shall be equal to at least two years from the Grant Date).

For purposes of the Continuous Presence Condition, should the relevant Beneficiary be at the same time an employee and a corporate officer of the same company or of two or more companies of the Group, the loss of one or more but not all of these functions during a Vesting Period shall not result in the loss of the right to acquire the relevant free Shares at the end of the relevant Vesting Period.

Pursuant to Article L. 225-197-3 of the French commercial code, during a Vesting Period, the Beneficiaries hold against the Company a right to acquire the relevant free Shares granted to him or her, which right is personal and may not be transferred until the end of the relevant Vesting Period. 

Prior to the completion of a Vesting Period of free Shares, the Beneficiaries do not own the relevant free Shares granted to them and, thus, are not shareholders of the Company with respect to such Shares, nor do they hold any rights attached to the existing Shares issued by the Company, including that prior to the completion of a Vesting Period of free Shares, no holder of free Shares will be entitled to receive any dividends or other distributions paid with respect to the free Shares.  

6.2 Internal mobility

In the event of transfer or temporary assignment of the Beneficiary within a company of the Group during a Vesting Period, resulting in (i) the termination of the initial employment agreement or arrangement and the entering into of a new employment agreement or arrangement or of a position as corporate officer, and/or (ii) a resignation of the Beneficiary from his or her position as corporate officer and the acceptance of a new position of corporate officer or the entering into of a new employment agreement or arrangement in one of such companies, the Continuous Presence Condition of the relevant Beneficiary shall be deemed satisfied for purposes of Article 6.1 above so that the relevant Beneficiary shall retain his or her right to acquire free Shares at the end of the relevant Vesting Period.

6.3 Disability 

In the event of Disability before the end of a Vesting Period,  all the relevant free Shares shall be definitively acquired by the relevant Beneficiary on the date of his or her Disability, provided that such request shall be notified to the Company within six (6) months by the Beneficiary or by his or her legally authorized representative.

6.4 Death

In the event of death of a Beneficiary during a Vesting Period, the relevant free Shares shall be definitively acquired on the date of a request for acquisition (demande d'attribution des actions) notified to the Company by his or her estate; provided that such request shall be notified to the Company within six (6) months from the date of death of the relevant Beneficiary in compliance with Article L. 225-197-3 of the French commercial code.

6.5 Retirement

In the event of retirement with full benefits, as determined by local law, of a Beneficiary during a Vesting Period, the Board of Directors of the Company may decide, effective on the date of such retirement, that all or part of the conditions set forth in Article 6.1 applicable to the relevant Beneficiary pursuant to his or her Grant Notice shall be waived or deemed met for all or part of the relevant Shares granted to him or her; provided, however, that the Continuous Presence Condition of the relevant Beneficiary shall have been satisfied between the Grant Date of the relevant free Shares and the date of his or her retirement. 

6.6  Change in Control

Unless otherwise provided by the Board of Directors, an agreement between a Group company and the Beneficiary or in the applicable Grant Notice, in the event of a Change in Control:

(i)  Where the successor corporation or parent or subsidiary of the successor corporation does not agree to assume or substitute for any outstanding Grant, for each Grant that is not assumed or substituted for and for which the consummation of the Change in Control occurs, should the Change in Control occur before the first anniversary of the Grant Date: all the Shares shall become fully and definitely acquired by the relevant Beneficiary on the first anniversary of the Grant Date; provided that (a) the Continuous Presence Condition shall be satisfied on the first anniversary of the Grant Date, (b) if not satisfied earlier, the Performance Conditions (if any) shall be satisfied automatically as if the Performance Conditions were achieved at target levels of performance on the first anniversary of the Grant Date, and (c) the relevant Shares shall be automatically subject to a mandatory additional 1-year Holding Period starting on the first anniversary of the Grant Date.

(ii)  Where the successor corporation or parent or subsidiary of the successor corporation does not agree to assume or substitute for any outstanding Grant, for each Grant that is not assumed or substituted for and for which the consummation of the Change in Control occurs, should the Change in Control occur on or after the first anniversary of the Grant Date: all the Shares shall become fully and definitely acquired by the relevant Beneficiary on the date of completion of the Change in Control (such date being the Vesting Date for purposes of this paragraph (ii)); provided that, should the date of completion date of the relevant Change in Control occur between the first and the second anniversary of the Grant Date, (a) the Continuous Presence 
Condition shall be satisfied on the completion date of the Change in Control, (b) if not satisfied earlier, the Performance Conditions (if any) shall be satisfied automatically as if the Performance Conditions were achieved at target levels of performance on the completion date of the Change in Control and (c) the relevant Shares shall be, if applicable, automatically subject to a mandatory additional Holding Period starting on the completion date of the Change in Control until the second anniversary of the Grant Date.

(iii) Notwithstanding anything in Article 6.6(i) or (ii) to the contrary, and except as would otherwise result in adverse tax consequences under Section 409A of the U.S. Internal Revenue Code (“Section 409A”), at any time prior to the completion date of the Change in Control, the Board of Directors may, in its sole discretion, provide for different treatment of free Shares in connection with a Change in Control, including, without limitation, cancelling all or part of the free Shares not yet acquired and paying instead to the relevant Beneficiaries a gross indemnity equal to the number of relevant free Shares (and Performance Conditions (if any) shall be satisfied automatically as if the Performance Conditions were achieved at target levels of performance) times the price per Share paid by the acquirer in the Change in Control, subject to such conditions as the Board of Directors determines in its discretion. The Board of Directors shall not be required to treat all Grants similarly for purposes of this Article 6.6.

(iv) For the purposes of this Article 6.6, a Grant will be considered assumed or substituted if, (a) following the Change in Control, the Grant confers the right to receive, for each Free Share subject to the Grant immediately prior to the Change in Control, the consideration (whether stock, cash, or other securities or property) or the fair market value, as determined by the Board of Directors in good faith, of the consideration received in the Change in Control by holders of ordinary shares of the Company for each such share held on the effective date of the transaction; provided, however, that if such consideration received in the Change in Control is not solely common stock or ordinary shares of the successor corporation or its parent, the Board of Directors may, with the consent of the successor corporation, provide that the consideration to be received for each Free Share shall be solely common stock or ordinary shares of the successor corporation or its parent equal in fair market value, as determined by the Board of Directors in good faith, to the per share consideration received by holders of ordinary shares of the Company in the Change in Control; (b) any securities of the successor corporation or its parent forming part of the Grant following the Change in Control are freely tradable on a major stock exchange; and (c) the Grant otherwise remains subject to the same terms and conditions that were applicable to the Grant immediately prior to the Change in Control.

Unless a Beneficiary is a party to a contract with the Company or any member of the Group providing for more favorable benefits, where the successor corporation or parent or subsidiary of the successor corporation does agree to assume or substitute for any outstanding Grant, in the event that an Involuntary Termination of a Beneficiary occurs within the Change in Control Period, and subject to the terms of the following paragraph (a) the Continuous Presence Condition shall be satisfied on the 55th day following such Involuntary Termination (or, if later and if necessary to satisfy any applicable Laws, the first anniversary of the Grant Date), (b) if not satisfied earlier, the Performance Conditions (if any) shall be satisfied automatically as if the Performance Conditions were achieved at target levels of performance on the 55th day following such Involuntary Termination (or, if later and if necessary to satisfy any applicable Laws, the first anniversary of the Grant Date), and (c) to the extent necessary to satisfy any applicable laws, the relevant Shares (or any securities substituted therefor) shall be automatically subject to a mandatory additional 1-year Holding Period starting on the first anniversary of the Grant Date; provided, however, that, if, under applicable law, it is not permitted to provide for different treatment depending on the cause of termination, then the provisions set forth above in this paragraph applicable to the Involuntary Termination will apply to all cases of termination.

The receipt of the benefits set forth in the immediately preceding paragraph is subject to the Beneficiary signing and not revoking the Company’s then-standard separation agreement and release of claims (which may include an agreement not to disparage any member of the Group, non-solicit provisions, and other standard terms and conditions) (the “Release” and such requirement, the “Release Requirement”), which must become effective and irrevocable no later than the 60th day following the Beneficiary’s Involuntary Termination (the “Release Deadline”).  In addition, with respect to any Beneficiary that is a U.S. taxpayer, to the extent the benefits under the preceding paragraph qualify as deferred compensation under Section 409A, they will not be provided until the Beneficiary has a “separation from service” (within the meaning of Section 409A) and if the Beneficiary is a “specified employee” within the meaning of 
Section 409A, then the benefits will be delayed to the extent necessary to avoid the imposition of the additional tax imposed under Section 409A, which means that the Beneficiary will receive payment on the date that is six months and one day following the Beneficiary’s separation from service, or, if earlier, the Beneficiary’s death.  Each benefit is intended to constitute a separate payment for purposes of U.S. Treasury Regulation Section 1.409A-2(b)(2). 

7. Holding Period

7.1 Principle

During a Holding Period of free Shares, if any, the relevant Beneficiaries will be the owner of the free Shares granted under the 2020 Plan and will be shareholders of the Company. As a consequence, they will benefit from all the rights granted to shareholders of the Company.

However, the free Shares shall not be available during a Holding Period and the Beneficiaries may not transfer or pledge the Shares, by any means, or convert them into bearer form.

At the end of a Holding Period, the relevant Shares will be fully available, subject to the provisions of the following paragraph. 

If and when the Company’s shares become listed on a regulated market, at the end of a Holding Period, the free Shares granted under the 2020 Plan may not be transferred during the “black-out” periods set forth in Article L. 225-197-1 of the French commercial code, i.e., as currently provided: 

–within a period of thirty (30) calendar days before the disclosure of an interim financial report or an annual report that the Company is required to make public;

–by the members of the board of directors or supervisory board, by the members of the management board or performing the duties of managing director or deputy managing director and by employees having knowledge of inside information, within the meaning of Article 7 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC, which has not been made public.

7.2 Specific situations

As an exception to the second paragraph of Article 7.1 above, the free Shares granted to the Beneficiaries referred to in Article 6.3 above or to the beneficiaries of a deceased Beneficiary referred to in Article 6.4 above may be freely transferred as from the date when the relevant Shares become acquired pursuant to Article 6.3 or 6.4, as applicable.

8. Characteristics of the Shares

The Shares definitively acquired shall be, at the Company’s option, new ordinary shares to be issued by the Company or existing ordinary Shares acquired by the Company.

As from its Vesting Date, an acquired Share shall be subject to all the provisions of the Bylaws.

An acquired Share shall be assimilated to existing ordinary shares of the Company and shall benefit from the same rights as from its Vesting Date. 

In compliance with article L. 225-197-1, II of the French commercial code, the Board of Directors has determined that, should a Beneficiary be an officer of the Company (i.e., managing director (directeur général) or deputy managing director (directeur général délégué), the relevant Beneficiary shall keep in registered form 
(nominatif pur) at least 10% of his or her free Shares until the termination of his or her functions as officer of the Company.

9. Delivery and holding of the Shares

At the end of a Vesting Period, the Company shall deliver to the Beneficiary the relevant free Shares granted under the 2020 Plan provided that the applicable conditions provided by Article 6 above are met. 

If a Vesting Date is not a working day, the delivery of the Shares shall be completed the first working day following the end of the relevant Vesting Period. 

The Shares that may be acquired under the 2020 Plan will be held, during the Holding Period (if any), under the registered form (nominatif pur) in an individual account opened in the name of the relevant Beneficiary at BNP Paribas Securities Services with a mention that they cannot be transferred prior to the expiration of the Holding Period (if any).  

Upon request, each Beneficiary shall receive a certificate of account registration;

If and when the Company becomes listed on a regulated market , at the end of a Holding Period (or the end of a Vesting Period if there is no Holding Period), the relevant Shares will have to remain under the nominative form (nominatif pur) at BNP Paribas Securities Services until the time they are transferred to make sure that the restrictions set forth in the last paragraph of Article 7.1 above are complied with. The conversion of the Shares in another form (bearer form or nominatif administré) is not allowed under the rules of the 2020 Plan. 

In the event that, as a consequence of the Grant of free Shares under the 2020 Plan, the Company or any of the companies of the Group shall be compelled to pay taxes, social costs or any other social security taxes or contributions in the name and on behalf of a Beneficiary, the Company retains the right to postpone or to forbid the delivery of the Shares on the Vesting Date until the relevant Beneficiary has paid to the Company or to the relevant company of the Group the amount corresponding to these taxes, social costs, or social security taxes or contributions.

10. Intermediary operations

In the event of an exchange of shares of the Company without payment in cash (soulte) resulting from a merger or spin-off of the Company completed in compliance with the applicable laws during a Vesting Period or a Holding Period, the parties receiving the shares of the Company in the relevant transaction shall substitute to the Company for purposes of the free Shares granted under the 2020 Plan and the terms and conditions of the 2020 Plan, including in particular the durations of the Vesting Period and of the Holding Period (if any) shall survive and apply to the rights and shares received by the Beneficiaries from the relevant receiving parties in compliance with article L. 225-197-1 III of the French commercial code.

Further, provisions of the previous paragraph shall apply mutatis mudandis in case of an exchange of shares of the Company resulting from a tender offer, a division or a grouping of shares completed during the Holding Period (if any) in compliance with applicable laws.

11. Adjustment

Should the Company proceed, during a Vesting Period, to an amortization, to a decrease of its share capital, to an amendment of the allocation of its profits among its shareholders, to a grant of free Shares to all its then existing shareholders, to a capitalization of reserves, profits or issue premiums, to a distribution of reserves or to any issue of equity securities or giving right to the allocation of equity securities including a preferential subscription right reserved to the shareholders, the maximum number of Shares granted under the 2020 Plan may be adjusted in order to take into account the impact of such operation by application, mutatis mutandis, of the adjustment provisions set forth under applicable French law to the holders of stock options (options de souscription ou d’achat d’actions). 

Each Beneficiary shall be notified to the Beneficiaries by any written means, including by regular mail, fax or e-mail of the terms of the relevant adjustment and of the consequences on the free Shares granted to him or her under the 2020 Plan; provided that the additional new free Shares which would be granted to him or her as a result of such adjustment shall be governed by the 2020 Plan. 

12. Amendment OF the 2020 Plan 

12.1 Principle

The 2020 Plan may be amended by the Board of Directors at any time; provided that no amendment, alteration, suspension or termination of the 2020 Plan shall impair the rights of any Beneficiary without the prior written consent of the relevant Beneficiary. 

In case of any amendment during a Vesting Period, the amended provisions shall apply to the Beneficiaries of the Shares effective on the date of the decision to amend the 2020 Plan taken by the Board of Directors or, if applicable, the written consent of the Beneficiary.

12.2 Notice of the amendments

Any amendment to the 2020 Plan shall be notified to the Beneficiaries by any written means, including by regular mail, fax or e-mail. 

13. Tax and social rules

The Beneficiary shall bear all taxes and costs imposed on him or her under applicable laws in connection with the Grant of free Shares to him or her under the 2020 Plan and shall pay such taxes and costs when due.

Each Beneficiary shall be solely liable with respect to any filing imposed on him or her in connection with the Grant of the free Shares to him or her under the 2020 Plan. 

14. Miscellaneous

14.1 Rights of Beneficiary in his or her capacity of employee or officer

Neither the 2020 Plan nor any right granted to a Beneficiary in connection with the Grant of free Shares shall confer upon such Beneficiary any right with respect to continuing the Beneficiary's employment or his term of office with the Company or any company of the Group, nor shall they interfere in any way with the Beneficiary's right or the Company's or company of the Group's right, as the case may be, to terminate or amend such employment or such term of office at any time, with or without cause.

14.2 Term of the 2020 Plan

The 2020 Plan shall have the duration necessary to fulfil the obligations set out therein.

14.3 Applicable law - Jurisdiction

This 2020 Plan and the Grant Notice  are, for their validity, interpretation and execution, subject to French law. The relevant court of the registered office of the Company shall be exclusively competent to determine any claim or dispute arising in connection herewith.

The provisions of this 2020 Plan and of the Grant Notice shall be interpreted in accordance with the legislation in France. 

In the event that one of the clauses is potentially or entirely deemed null and void and unwritten, the other provisions of this Plan shall continue to have full effect.

14.4 Provisions Applicable to Beneficiaries Located Outside of France

To facilitate compliance with laws and the administration of the 2020 Plan in countries outside of France, the Board of Directors may (i) establish subplans and modify the terms and conditions of, as well as the procedures and rules applicable to, Grants of free Shares to Beneficiaries residing and/or providing services outside of France and in particular locations, and (ii) take any action, before or after Grant is made, that it deems advisable to obtain approval or comply with any necessary local governmental regulatory exemptions or approvals. Without limiting the generality of the foregoing, the Board of Directors may adopt rules, procedures and subplans with provisions that (A) limit or modify rights on eligibility to receive a Grant under the 2020 Plan or rights applicable upon death, disability, retirement, termination of employment and Change in Control, and (B) address the payment of income tax, social insurance contributions and payroll taxes, withholding procedures and handling of any indicia of ownership of the Shares which may vary with local requirements.

Acknowledgement of 2020 Plan

By accepting a Grant under the 2020 Plan through the Company's electronic acceptance procedure, the Beneficiary represents that he or she has been provided with a copy of the 2020 Plan which he or she has perused and acknowledges and agrees that the provisions of the 2020 Plan apply to and are enforceable against him or her.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00312-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00312-of-00352.parquet"}]]